Sheba News Featured NBA Dikembe Mutombo

NBA All-Star Dikembe Mutombo Visits Sheba to Jumpstart Collaboration with the Republic of Congo

NBA all-star legend Dikembe Mutombo recently travelled to Israel to meet with international medical experts at Sheba Medical Center. The goal of Mutombo’s visit was to discuss a possible 2019 collaboration between Sheba and the Biamba Marie Mutombo Hospital in the Democratic Republic of Congo.

Sheba News Featured IAC 2018

IAC 2018 National Conference in Florida: Visionary Doctor from Sheba Speaks About the Future of Medicine

The 2018 Israel American Council (IAC) National Conference was held recently at the Diplomat Beach Resort in Hollywood, Florida. On December 1, Dr. Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center was honored as a guest speaker in an engaging panel discussion on “The Future of Medicine.”

Sheba News Featured Zambia

Team from Sheba Medical Center – First Responders in Zambia Cholera Outbreak

The Humanitarian Response Team from the Israel Center for Disaster Medicine at Sheba Medical Center was the first international team of doctors, nurses, and lab technicians to respond to the urgent call for help following an outbreak of cholera in Lusaka, Zambia. Cholera is unheard of in Israel, just like in all Western nations. However, Sheba held fast to their commitment to share medical excellence under all circumstances.

Sheba News Featured New Guinea

Sheba Doctors Restore Sight to Residents of Papua New Guinea

A team comprised of several Israeli ophthalmologists and nurses recently set sail for the South Pacific paradise island of Papua New Guinea, where they will perform advanced cataract surgeries. The head of the team is Dr. Eva Platner, an ophthalmologist, and all of the medical specialists represent The Israel Center for Disaster Medicine and Humanitarian Response at Sheba Medical Center.

Sheba News Featured Angelman Syndrome

Angelman Syndrome Foundation Opens New Clinic in Israel

The Angelman Syndrome Foundation (ASF) recently expanded their international reach into Israel, collaborating with The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Israel to open a new clinic. ASF’s mission is to advance awareness and treatment of AS, and the foundation has funded numerous research grants and clinics. With the addition of the Israeli clinic and another new clinic in The Children’s Hospital of Eastern Ontario in Ottawa, Canada, the ASF now has 10 global locations (eight of which are in the United States).

Sheba News Featured Vaccines

Top Israeli Doctor Points to Vaccines as Contributing to the Rising Rate of Autoimmune Diseases

Dr. Yehuda Shoenfeld, nicknamed the “Godfather of Autoimmunology,” recently published an article in Pharmacological Research with his colleagues that explores how vaccines may be contributing to the growing epidemic of autoimmune diseases. The article is based on massive amounts of research that have been accumulating over the past 15 years.

Sheba News Featured neonatal intensive care unit 2

Sheba’s neonatal intensive care unit stands out and was awarded for its excellence by the Ministry of Health

For the fifth year running, Sheba Medical Center’s Neonatal Intensive Care Unit was awarded the “Excellence in Neonatal Intensive Care” title by the Ministry of Health.

Fusion prostate biopsy - smart test for prostate cancer now available at Sheba

Fusion prostate biopsy – smart test for prostate cancer now available at Sheba

A prostate biopsy is recommended in case of suspected prostate cancer due to increased PSA levels or an abnormal rectal examination, or both.
A fusion biopsy is a smart biopsy guided by MRI scanning. During the test, suspicious areas are noted by the radiologist, and the MRI data is combined with ultrasound images. This combination (fusion) makes it possible to target the biopsy more accurately to suspicious areas, rather than blind piercing, and to increase the rate of disease detection.
The biopsy is managed by a urologist, who takes a small tissue sample from the prostate using a small needle. Then, a tissue sample is sent to the pathological laboratory for microscopic examination.

KidneyCure Raises 4m

KidneyCure Raises $4m for New Kidney Disease Treatment

KidneyCure, the Israeli cell therapy company based in Tel Aviv, is developing treatment for end-stage renal disease. This innovative company recently announced the financial support of new investors, Aurum Ventures, controlled by Morris Kahn, and Direct Insurance –Financial Investments. Altogether, the addition of these two investors brings the total capital raised by KidneyCure to $4 million.

MedAware Develops a Safety Net to Prevent Risky Prescription Errors

MedAware Develops a Safety Net to Prevent Risky Prescription Errors

Approximately four billion prescriptions for medication are filled every year in the United States. Within this staggering number, anywhere from four to eight million of these medications will involve potentially life-threatening mistakes. In response, MedAware has developed a technological solution to identify and prevent dangerous prescription errors in real-time. Their innovative technology was tested recently in a live clinical trial at Sheba Medical Center, and the MedAware notifications were found to be on time and accurate 80% of the time.